High hopes for RANKL: will the mouse model live up to its promise?

Por Tanos, Tamara, Brisken, Cathrin
Publicado em 2011

A new Achilles Heel in breast cancer?

Por Sflomos, George, Brisken, Cathrin
Publicado em 2013

From normal cell types to malignant phenotypes

Por Yalcin-Ozuysal, Özden, Brisken, Cathrin
Publicado em 2009

Hormone Action in the Mammary Gland

Por Brisken, Cathrin, O’Malley, Bert
Publicado em 2010

Prolactin signaling and Stat5: going their own separate ways?

Por Brisken, Cathrin, Ayyanan, Ayyakkannu, Doppler, Wolfgang
Publicado em 2002

Amphiregulin is an essential mediator of estrogen receptor α function in mammary gland development

Por Ciarloni, Laura, Mallepell, Sonia, Brisken, Cathrin
Publicado em 2007

An Ex vivo Model to Study Hormone Action in the Human Breast

Por Sflomos, George, Shamseddin, Marie, Brisken, Cathrin
Publicado no J Vis Exp (2015)

Progesterone and Overlooked Endocrine Pathways in Breast Cancer Pathogenesis

Por Brisken, Cathrin, Hess, Kathryn, Jeitziner, Rachel
Publicado no Endocrinology (2015)

Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland

Por Mallepell, Sonia, Krust, Andrée, Chambon, Pierre, Brisken, Cathrin
Publicado em 2006

The signaling domain of the erythropoietin receptor rescues prolactin receptor-mutant mammary epithelium

Por Brisken, Cathrin, Socolovsky, Merav, Lodish, Harvey F., Weinberg, Robert
Publicado em 2002

ER and PR signaling nodes during mammary gland development

Por Tanos, Tamara, Rojo, Lucia Jimenez, Echeverria, Pablo, Brisken, Cathrin
Publicado em 2012

Does cancer start in the womb? Altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors

Por Soto, Ana M., Brisken, Cathrin, Schaeberle, Cheryl, Sonnenschein, Carlos
Publicado em 2013

p21(WAF1/Cip1) is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation

Por Devgan, Vikram, Mammucari, Cristina, Millar, Sarah E., Brisken, Cathrin, Dotto, G. Paolo
Publicado em 2005

Cyclin D1 Enhances the Response to Estrogen and Progesterone by Regulating Progesterone Receptor Expression

Por Yang, Chuanwei, Chen, Li, Li, Cuiqi, Lynch, Mary C., Brisken, Cathrin, Schmidt, Emmett V.
Publicado em 2010

A paracrine role for the epithelial progesterone receptor in mammary gland development

Por Brisken, Cathrin, Park, Sissela, Vass, Tibor, Lydon, John P., O’Malley, Bert W., Weinberg, Robert A.
Publicado em 1998

An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells

Por Duss, Stephan, André, Sylvie, Nicoulaz, Anne-Laure, Fiche, Maryse, Bonnefoi, Hervé, Brisken, Cathrin, Iggo, Richard D
Publicado em 2007

In vivo reprogramming of non-mammary cells to an epithelial cell fate is independent of amphiregulin signaling

Por George, Andrea L., Boulanger, Corinne A., Anderson, Lisa H., Cagnet, Stéphanie, Brisken, Cathrin, Smith, Gilbert H.
Publicado no J Cell Sci (2017)

Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics

Por Booth, Brian W., Boulanger, Corinne A., Anderson, Lisa H., Jimenez-Rojo, Lucia, Brisken, Cathrin, Smith, Gilbert H.
Publicado em 2009

Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland

Por Beleut, Manfred, Rajaram, Renuga Devi, Caikovski, Marian, Ayyanan, Ayyakkannu, Germano, Davide, Choi, Yongwon, Schneider, Pascal, Brisken, Cathrin
Publicado em 2010

Progesterone and Wnt4 control mammary stem cells via myoepithelial crosstalk

Por Rajaram, Renuga Devi, Buric, Duje, Caikovski, Marian, Ayyanan, Ayyakkannu, Rougemont, Jacques, Shan, Jingdong, Vainio, Seppo J, Yalcin-Ozuysal, Ozden, Brisken, Cathrin
Publicado no EMBO J (2015)